S&P 500   3,768.54 (-1.34%)
DOW   30,923.29 (-1.11%)
QQQ   304.31 (-1.57%)
AAPL   120.12 (-1.59%)
MSFT   226.80 (-0.33%)
FB   258.27 (+1.12%)
GOOGL   2,042.42 (+1.54%)
TSLA   619.74 (-5.12%)
AMZN   2,984.92 (-0.67%)
NVDA   494.44 (-3.47%)
BABA   230.97 (-2.24%)
CGC   31.12 (-6.38%)
GE   13.57 (+0.97%)
MU   84.26 (-5.44%)
NIO   39.38 (-5.18%)
AMD   78.05 (-3.48%)
T   28.94 (+0.77%)
F   11.94 (-1.89%)
ACB   9.77 (-6.60%)
DIS   187.79 (-2.32%)
BA   225.47 (-1.35%)
NFLX   512.09 (-1.65%)
BAC   36.55 (+0.36%)
S&P 500   3,768.54 (-1.34%)
DOW   30,923.29 (-1.11%)
QQQ   304.31 (-1.57%)
AAPL   120.12 (-1.59%)
MSFT   226.80 (-0.33%)
FB   258.27 (+1.12%)
GOOGL   2,042.42 (+1.54%)
TSLA   619.74 (-5.12%)
AMZN   2,984.92 (-0.67%)
NVDA   494.44 (-3.47%)
BABA   230.97 (-2.24%)
CGC   31.12 (-6.38%)
GE   13.57 (+0.97%)
MU   84.26 (-5.44%)
NIO   39.38 (-5.18%)
AMD   78.05 (-3.48%)
T   28.94 (+0.77%)
F   11.94 (-1.89%)
ACB   9.77 (-6.60%)
DIS   187.79 (-2.32%)
BA   225.47 (-1.35%)
NFLX   512.09 (-1.65%)
BAC   36.55 (+0.36%)
S&P 500   3,768.54 (-1.34%)
DOW   30,923.29 (-1.11%)
QQQ   304.31 (-1.57%)
AAPL   120.12 (-1.59%)
MSFT   226.80 (-0.33%)
FB   258.27 (+1.12%)
GOOGL   2,042.42 (+1.54%)
TSLA   619.74 (-5.12%)
AMZN   2,984.92 (-0.67%)
NVDA   494.44 (-3.47%)
BABA   230.97 (-2.24%)
CGC   31.12 (-6.38%)
GE   13.57 (+0.97%)
MU   84.26 (-5.44%)
NIO   39.38 (-5.18%)
AMD   78.05 (-3.48%)
T   28.94 (+0.77%)
F   11.94 (-1.89%)
ACB   9.77 (-6.60%)
DIS   187.79 (-2.32%)
BA   225.47 (-1.35%)
NFLX   512.09 (-1.65%)
BAC   36.55 (+0.36%)
S&P 500   3,768.54 (-1.34%)
DOW   30,923.29 (-1.11%)
QQQ   304.31 (-1.57%)
AAPL   120.12 (-1.59%)
MSFT   226.80 (-0.33%)
FB   258.27 (+1.12%)
GOOGL   2,042.42 (+1.54%)
TSLA   619.74 (-5.12%)
AMZN   2,984.92 (-0.67%)
NVDA   494.44 (-3.47%)
BABA   230.97 (-2.24%)
CGC   31.12 (-6.38%)
GE   13.57 (+0.97%)
MU   84.26 (-5.44%)
NIO   39.38 (-5.18%)
AMD   78.05 (-3.48%)
T   28.94 (+0.77%)
F   11.94 (-1.89%)
ACB   9.77 (-6.60%)
DIS   187.79 (-2.32%)
BA   225.47 (-1.35%)
NFLX   512.09 (-1.65%)
BAC   36.55 (+0.36%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 TrupanionClover Health InvestmentsAdvanzeon SolutionsMolina Healthcare
SymbolNASDAQ:TRUPNASDAQ:CLOVOTCMKTS:CHCRNYSE:MOH
Price Information
Current Price$86.40$7.29$0.11$210.41
52 Week RangeBuyBuyN/ABuy
MarketRank™
Overall Score1.21.50.51.5
Analysis Score1.33.30.01.4
Community Score2.73.32.42.0
Dividend Score0.00.00.00.0
Ownership Score1.70.80.01.7
Earnings & Valuation Score0.60.00.02.5
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuy
Consensus Price Target$86.60$14.00N/A$220.69
% Upside from Price Target0.23% upside92.04% upsideN/A4.89% upside
Trade Information
Market Cap$3.61 billion$858.02 million$12.59 million$12.30 billion
Beta2.01N/A2.760.74
Average Volume422,81119,261,25223,700367,722
Sales & Book Value
Annual Revenue$383.94 millionN/A$300,000.00$16.83 billion
Price / Sales8.88N/A41.970.73
Cashflow$0.08 per shareN/AN/A$12.29 per share
Price / Cash1,063.69N/AN/A17.12
Book Value$3.91 per shareN/A($0.40) per share$31.26 per share
Price / Book22.10N/A-0.266.73
Profitability
Net Income$-1,810,000.00N/A$-3,260,000.00$737 million
EPS($0.05)N/AN/A$11.57
Trailing P/E RatioN/A0.000.0015.77
Forward P/E RatioN/A15.10
P/E GrowthN/AN/AN/A1.65
Net Margins-0.37%N/A-1,131.46%4.37%
Return on Equity (ROE)-1.22%N/AN/A43.16%
Return on Assets (ROA)-0.60%N/A-244.73%11.35%
Dividend
Annual PayoutN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.21%N/AN/A0.93%
Current Ratio1.56%0.33%0.07%1.96%
Quick Ratio1.56%0.33%0.07%1.96%
Ownership Information
Institutional Ownership Percentage89.43%49.05%N/A94.89%
Insider Ownership Percentage13.61%N/A16.50%1.07%
Miscellaneous
Employees911327210,500
Shares Outstanding39.47 million103.50 million119.91 million58.00 million
Next Earnings Date4/29/2021 (Estimated)N/AN/A4/28/2021 (Confirmed)
OptionableOptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.